PE‐Sor (COL25A1, TGFB1, DACT1, RBP5, PRKD2, GC, ELF5, LHX8 and SCNN1A) was used to predict sorafenib response in hepatocellular carcinoma (HCC) patients. This evidence concerns the gene GC and hepatocellular carcinoma.